Entero Therapeutics
NASDAQ: ENTO
Healthcare
Biotechnology
Global Rank
#43751
Country Rank
#5353
Market Cap
6.42 M
Price
4.04
Change (%)
7.34%
Volume
143,933
Entero Therapeutics's latest marketcap:
6.42 M
As of 10/26/2025, Entero Therapeutics's market capitalization has reached $6.42 M. According to our data, Entero Therapeutics is the 43751th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.42 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -17,377,321 |
| Shares Out | 1.59 M |
| EPS (ttm) | -10.85 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 11/12/2025 |
Market Cap Chart
Data Updated: 10/26/2025
Entero Therapeutics's yearly market capitalization.
Entero Therapeutics has seen its market value drop from $45.4 M to $6.42 M since 2016, representing a total decrease of 85.86% and an annual compound decline rate (CAGR) of 19.89%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 10/26/2025 | $6.42 M | 113.33% | 43751 |
| 12/31/2024 | $3 M | 7.14% | 42359 |
| 12/29/2023 | $2.8 M | -45.1% | 41113 |
| 12/30/2022 | $5.1 M | -71.67% | 38238 |
| 12/31/2021 | $18 M | -38.98% | 33208 |
| 12/31/2020 | $29.5 M | 8.06% | 27617 |
| 12/31/2019 | $27.3 M | 33.82% | 25046 |
| 12/31/2018 | $20.4 M | -51.66% | 25335 |
| 12/29/2017 | $42.2 M | -7.05% | 22423 |
| 12/30/2016 | $45.4 M | 19812 |
Company Profile
Entero Therapeutics was founded in 2014 in United States.
The company went public on 10/11/2016
on the Nasdaq Stock Market.
With 2 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Entero Therapeutics's (ENTO) current market cap?As of 10/26/2025, Entero Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $6.42 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Entero Therapeutics (ENTO) rank globally by market cap?Entero Therapeutics global market capitalization ranking is approximately 43751 as of 10/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.